**Core Concept**
Multiple Endocrine Neoplasia Type 2A (MEN IIa) is a rare genetic disorder characterized by the occurrence of tumors in multiple endocrine glands, primarily the thyroid and adrenal glands. The condition is caused by mutations in the RET proto-oncogene, leading to the development of medullary thyroid carcinoma, pheochromocytoma, and other associated features.

**Why the Correct Answer is Right**
MEN IIa is characterized by the presence of medullary thyroid carcinoma (MTC) and pheochromocytoma, which are both ectopic tumors of neural crest origin. MTC arises from the parafollicular cells of the thyroid gland, while pheochromocytoma develops from the chromaffin cells of the adrenal medulla. The combination of these two tumors is a hallmark of MEN IIa. In contrast, pituitary tumors and neuromas are not typically associated with MEN IIa.

**Why Each Wrong Option is Incorrect**
**Option A:** Pituitary tumors are more commonly associated with Multiple Endocrine Neoplasia Type 1 (MEN I), not MEN IIa.
**Option B:** Neuromas are not a typical feature of MEN IIa, although they can occur in MEN I and other neuroendocrine disorders.
**Option C:** This option suggests that both pituitary tumors and neuromas are features of MEN IIa, which is incorrect.
**Option D:** This option suggests that pituitary tumors are a feature of MEN IIa, which is incorrect.

**Clinical Pearl / High-Yield Fact**
MEN IIa is a highly penetrant disorder, meaning that individuals with the mutation are almost certain to develop the associated tumors. Early detection and screening are critical to prevent the development of these tumors and to improve patient outcomes.

**✓ Correct Answer: A. ad**